The analysis of U.S. healthcare finds that it is:

• A. The best in the world in all aspects.
• B. Relatively strong in cancer care, weaker in prevention-related mortality.
• C. Weak in all aspects.
• D. Not compared to other countries.

Answer: (B)

Think about how health systems perform across different parts of care. The United States tends to excel in high-tech, specialized treatments and has exceptionally strong cancer care due to heavy investment in research, advanced diagnostics, and top-tier cancer centers. Those strengths translate into relatively favorable outcomes in many cancer areas.

At the same time, prevention-related mortality—the deaths that could be avoided with effective prevention, early screening, and strong primary care—lags behind. Barriers like uneven access to care, disparities, and gaps in preventive services contribute to higher preventable deaths compared with some other high-income countries.

So this option best reflects the nuanced reality: strong performance in cancer care paired with weaknesses in prevention-related mortality. It’s not accurate to say the U.S. is best in everything, or weak in all areas, and analyses do compare it with other countries rather than treat it as isolated.